Application of syringaldehyde to preparation of radiocancerogenesis protection drug

A radiation carcinogenic and syringaldehyde technology, which is applied in the application field of syringaldehyde in the preparation of radiation carcinogenic protective drugs, can solve the problems of reducing the radiation carcinogenic effect rate, lack of medical protection measures, and affecting the combat effectiveness of troops, so as to reduce the proportion of primitive cells, Reduce the proliferation of bone marrow tissue, the effect of small toxicity
CN104706628AInactive Publication Date: 2015-06-17INST OF RADIATION MEDICINE ACAD OF MILITARY MEDICAL SCI OF THE PLA

Patent Information

Authority / Receiving Office
CN · China
Current Assignee / Owner
INST OF RADIATION MEDICINE ACAD OF MILITARY MEDICAL SCI OF THE PLA
Publication Date
2015-06-17
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention discloses a novel application of syringaldehyde to preparation of drugs. The novel application of the syringaldehyde to preparation of drugs is application of syringaldehyde to preparation of a radiocancerogenesis protection drug. The radiological protection drug with syringaldehyde which serves as an active component has the following advantages that the drug is low in toxicity and free of obvious adverse reactions, the treatment effect is obvious, the drug is administrated by a dosage of 10mg per mouse in 30 minutes before radiation, the low-dosage radiation accommodation adsorption is 7Gy, the occurrence rate of spleen neoplasms of the mouse is reduced by 20%, the occurrence rate of tumors of liver is reduced by 15% and the occurrence rate of thymic tumor is reduced by 24% after radiating for 15 months, the injury to the animal hemopoietic system caused by radiating can be effectively protected under the concentration of 100mg / Kg, the myeloid erythroid ratio and the original cell ratio of the radiated mouse bone marrow are reduced, and the spleen, the liver and the thymus of the radiated animal are protected. The properties show that the syringaldehyde takes a unique role in the radiating and reducing the occurrence of the cancer; the syringaldehyde has a wide application prospect in the national defense medical field.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention relates to the application of syringaldehyde in the preparation of radiocarcinogenic protective drugs. Background technique

[0002] The application of nuclear energy in the national economy and military fields is becoming more and more extensive, and the potential harm of ionizing radiation or nuclear radiation to human beings is also increasing. Radiation-induced carcinogenesis is one of the main forms of radiation damage and health hazards. It is a random effect and has a serious impact on human health and life. In some special combat readiness and battlefield environments in the national defense field of our country, such as the army’s underground tunnels, nuclear-powered submarines, the daily installation and maintenance of nuclear weapons of the Second Artillery Force, storage management, special equipment transportation and combat readiness training, there will be a large number of scientific research personnel and training personn...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More